Anti-CD20 (Rituximab biosimilar - IgA2 isotype)
Product | Unit size | Cat. code | Docs. | Qty. | Price | |
---|---|---|---|---|---|---|
Anti-hCD20-hIgA2 Human CD20 (Rituximab) antibody - Human IgA2 |
Show product |
100 µg 3 x 100 µg |
hcd20-mab7
|
|
Human IgA2 monoclonal antibody (mAb) against human CD20
Anti-hCD20-hIgA2 features the constant region of the human IgA2 isotype and the variable region of rituximab.
Rituximab is a mouse/human chimeric monoclonal antibody that targets the CD20 antigen found on the surface of malignant and normal B lymphocytes.
The binding of rituximab to CD20 results in cell destruction through different mechanisms including direct signaling of apoptosis, complement activation, and cell-mediated cytotoxicity.
Rituximab has been approved by the FDA to treat various lymphoid malignancies, including B-cell non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.
Anti-hCD20-hIgA2 was generated by recombinant DNA technology. It has been produced in Chinese hamster ovary (CHO) cells and purified by affinity chromatography with peptide M.
More isotypes of this antibody are available and can be used for comparison of biological activities such as ADCC (see below or in the 'upon request' section). InvivoGen also provides type I and type II anti-hCD20 mAbs featuring the variable regions of Ofatumumab or Obinutuzumab, with either native or engineered Fc regions.
Back to the topSpecifications
Target: Human CD20
Clonality: Monoclonal antibody
Clone: Rituximab (Anti-hCD20-hIgG1, kappa)
Isotype: Human IgA2, kappa
Control: Human IgA2
Source: CHO cells
Formulation: 0.2 µm filtered solution in TRIS buffer with glycine, saccharose, and stabilizing agents
Purity: Purified by affinity chromatography with peptide M
Tested application: Flow cytometry and ADCC
Quality control:
- Binding of Anti-hCD20-hIgA2 to human CD20 has been tested using flow cytometry.
- The complete sequence of this antibody has been verified.
- The absence of bacterial contamination (e.g. lipoproteins and endotoxins) has been confirmed using HEK-Blue™ TLR2 and HEK-Blue™ TLR4 cells.
Contents
Anti-hCD20-hIgA2 purified monoclonal antibody is provided azide-free and lyophilized. It is available in two quantities:
- hcd20-mab7: 100 µg
- hcd20-mab7-03: 3 x 100 µg
Product is shipped at room temperature.
Upon receipt, store lyophilized antibody at -20°C.
Back to the top